Table 2.
Simultaneous plasma and CSF PK parameters after a single 5 mg/kg dose in non-human primates
Animal | τ (h) | Ka (h −1) | V1/F (L/kg) | Ke (h −1) | K12 (h−1) | K21 (h −1) | CSF CL (ml/h) | ||
---|---|---|---|---|---|---|---|---|---|
1 | 0.76 | 12.5 | 41.5 | 0.23 | 7.0 × 10−6 | 0.805 | 3.0 | 8.1 | |
2 | 0.78 | 53.5 | 40.0 | 0.18 | 4.7 × 10−6 | 0.420 | 3.9 | 4.2 | |
3 | 2.75 | 44.2 | 24.2 | 0.16 | 16.5 × 10−6 | 0.913 | 4.3 | 9.1 | |
Mean | 1.43 | 36.7 | 35.2 | 0.19 | 9.4 × 10−6 | 0.71 | 3.7 | 7.1 | |
SD | 1.14 | 21.5 | 9.6 | 0.04 | 6.3 × 10−6 | 0.26 | 0.7 | 2.6 |
τ time-delay for absorption of oral drug, Ka absorption rate constant, V1/F model-estimated apparent volume of distribution, Ke plasma elimination rate constant, K12 rate constant for transfer from plasma to CSF, K21 rate constant for transfer from CSF to plasma, model-estimated plasma half-life, CSF CL clearance from CSF